Skip to main content

Interleukin Genetics Expands Research Collaboration with Alticor Subsidiary

NEW YORK, July 1 (GenomeWeb News) - Interleukin Genetics of Waltham, Mass., today announced a research agreement with Access Business Group, a subsidiary of Alticor, to conduct research into the development of a test to identify individuals with specific genetic variations that affect how people gain and maintain weight.

 

The agreement also includes the development of nutritional products targeting those who are overweight, but not obese.

 

Interleukin is eligible to receive up to $1.9 million in additional research funding over 12 months, beginning on July 1, 2004 contingent on performance milestones.

The project is based on the perilipin gene licensed by Interleukin, the company said in a statement.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.